Novel ZBTB44-JAK2 fusion detected in a patient with Ph-like ALL. Exon 2 of ZBTB44 fused in-frame to exon 19 of JAK2, conserving an intact kinase domain. The fusion was validated by reverse transcriptase polymerase chain reaction and Sanger sequencing. The figure was adapted from Arriba output.